<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Molecular Templates, Inc.

    Molecular Templates, Inc.

    Molecular Templates is focused on the discovery, development, and commercializatio...

    Molecular Templates is focused on the discovery...

    Filing Type:    PU
    ANI Pharmaceuticals, Inc.

    ANI Pharmaceuticals, Inc.

    An emerging leader in the specialty pharmaceuticals industry, ANI Pharmaceuticals ...

    An emerging leader in the specialty pharmaceuti...

    Filing Type:    PU
    AVROBIO, Inc.

    AVROBIO, Inc.

    AVROBIO, Inc., a leader in lentiviral-based gene therapies, is a clinical stage co...

    AVROBIO, Inc., a leader in lentiviral-based gen...

    Filing Type:    PU
    GenMark Diagnostics, Inc.

    GenMark Diagnostics, Inc.

    GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular di...

    GenMark Diagnostics (NASDAQ: GNMK) is a leading...

    Filing Type:    PU
    Solid Biosciences Inc.

    Solid Biosciences Inc.

    Solid Biosciences is a life science company focused solely on finding meaningful t...

    Solid Biosciences is a life science company foc...

    Filing Type:    PU
    SeaSpine Holdings Corporation

    SeaSpine Holdings Corporation

    We are a global medical technology company focused on the design, development and ...

    We are a global medical technology company focu...

    Filing Type:    PU
    Avinger, Inc.

    Avinger, Inc.

    Avinger is a commercial-stage medical device company that designs, manufactures an...

    Avinger is a commercial-stage medical device co...

    Filing Type:    PU
    Pulse Biosciences, Inc

    Pulse Biosciences, Inc

    Pulse Biosciences is a bioelectric medicine company pursuing commercial introducti...

    Pulse Biosciences is a bioelectric medicine com...

    Filing Type:    PU
    Global Cancer Technology, Inc

    Global Cancer Technology, Inc

    Global Cancer Technology (“GCT”) is an emerging medical technology company with nu...

    Global Cancer Technology (“GCT”) is an emerging...

    Amount Raised:    $82,711.00
    Fundraising Status:    EC
    Filing Type:    CF
    ©2026 National Investor Network. All Rights Reserved.